Dr. Reddy's Laboratories Ltd.
(NYSE : RDY)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Generic
symbolcompany%chnglast%shortavg$volume
ZTSZoetis, Inc. -0.42%206.141.9%$417.32m
TEVATeva Pharmaceutical Industries Ltd. -0.27%9.182.0%$90.22m
RDYDr. Reddy's Laboratories Ltd. -1.28%62.582.0%$6.45m
JAGXJaguar Health, Inc. 1.32%0.962.6%$6.28m
TXMDTherapeuticsMD, Inc. 0.97%0.3514.2%$2.61m
ABEOAbeona Therapeutics, Inc. 0.92%0.272.5%$1.92m
TAROTaro Pharmaceutical Industries Ltd. -2.33%48.566.6%$0.95m
COCPCocrystal Pharma, Inc. 2.56%0.600.0%$0.55m
LFVNLifeVantage Corp. -0.15%6.543.6%$0.28m
CPHIChina Pharma Holdings, Inc. 3.21%0.420.1%$0.11m

Company Profile

Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.